Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform


You May Also Like

Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments

NEW YORK, April 18, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional ...

Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2

Encouraging results evaluating HS-110 in combination with Bristol-Myers Squibb’s anti-PD-1 checkpoint inhibitor, nivolumab (Opdivo®) ...